PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: PharmaJet, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CDC Awards Contract to PharmaJet for Development of a Needleless Intradermal Vaccine Delivery Device - Funding advances development of needle‐free injector that enables reduced doses and antigen‐sparing of vaccines
CDC Awards Contract to PharmaJet for Development of a Needleless Intradermal Vaccine Delivery Device

 

NewswireToday - /newswire/ - Golden, CO, United States, 2011/02/01 - Funding advances development of needle‐free injector that enables reduced doses and antigen‐sparing of vaccines.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Centers for Disease Control (CDC) has awarded PharmaJet with a substantial grant to develop needle‐free injection devices for intradermal (ID) vaccine delivery. Accurate vaccine delivery into the layers of skin, rather than into muscle, holds the promise of providing protection from disease and doing so with less vaccine, less pain and decreased demand on expensive logistics, such as transportation and cold chain.

Intradermal delivery has the potential to reduce the amount of vaccine required, by as much as 80% in some cases, leading to cost savings and expanded coverage for vaccines in limited supply. The current needle‐based “Mantoux” method of ID delivery is technically difficult, painful for the patient and time consuming. PharmaJet aims to eliminate this barrier by bringing to market a needle‐free injection technology that is:

1) easy and intuitive to use in individual or mass vaccination settings;
2) at a competitive cost;
3) reliable for a broad spectrum of skin types (e.g., infants, children, youth and adults);
4) used with any vaccine licensed or considered appropriate for ID delivery; and
5) safe; eliminating needlestick injuries and needle reuse.

A mechanism for reliable, affordable and simple ID delivery could immediately address significant and meaningful public health issues: (a) helping to reduce the cost of vaccine delivery programs worldwide, and (b) facilitating the accurate and consistent intradermal delivery of vaccines, enabling more effective care. The PharmaJet device will enable routine public health use of lower‐cost dose‐sparing strategies for mass vaccination and pandemic vaccine stockpile management.

“The award of this SBIR Phase II contract will advance development of our technology, permitting dose‐sparing stategies for some vaccines, improving the efficacy of others and positioning PharmaJet to play a pivotal role in global vaccine delivery,” says Dr. Michael Royals, PharmaJet’s Head, Global Technology Development and Chief Science Officer. “A non‐needle based solution that enables easy delivery of injectable vaccine will assist initiatives such as the Global Polio Eradication Program, and fits with PharmaJet’s core mission to help lower disease transmission and global disease burden.”

About PharmaJet, Inc. and Needle‐free Injection Technology
PharmaJet’s needle‐free injection technology delivers drugs and vaccines to intramuscular, subcutaneous and intradermal tissue depths. PharmaJet injectors use pressure to create a fine stream of liquid that penetrates the skin, delivering doses to the desired depth, while eliminating needle‐stick risk and the burden of sharps waste management. Further benefits of PharmaJet injectors include the potential for dose‐sparing of vaccines, reducing the overall cost of vaccine delivery. The PharmaJet system (pharmajet.com) has been well received in the developed world, and is also extremely advantageous in the developing world due to its usability, affordability and improved safety features.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: PharmaJet, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CDC Awards Contract to PharmaJet for Development of a Needleless Intradermal Vaccine Delivery Device

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Regina Todd - PharmaJet.com 
410-209-2389 todd[.]pharmajet.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any PharmaJet, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From PharmaJet, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)